158 related articles for article (PubMed ID: 38774451)
21. Flow cytometric analysis of SOX11: a new diagnostic method for distinguishing B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma from mantle cell lymphoma.
Wasik AM; Priebe V; Lord M; Jeppsson-Ahlberg Å; Christensson B; Sander B
Leuk Lymphoma; 2015 May; 56(5):1425-31. PubMed ID: 25120048
[TBL] [Abstract][Full Text] [Related]
22. SAMHD1 protects cancer cells from various nucleoside-based antimetabolites.
Herold N; Rudd SG; Sanjiv K; Kutzner J; Bladh J; Paulin CBJ; Helleday T; Henter JI; Schaller T
Cell Cycle; 2017 Jun; 16(11):1029-1038. PubMed ID: 28436707
[TBL] [Abstract][Full Text] [Related]
23. miR-223 is repressed and correlates with inferior clinical features in mantle cell lymphoma through targeting SOX11.
Zhou K; Feng X; Wang Y; Liu Y; Tian L; Zuo W; Yi S; Wei X; Song Y; Qiu L
Exp Hematol; 2018 Feb; 58():27-34.e1. PubMed ID: 29158064
[TBL] [Abstract][Full Text] [Related]
24. SOX11 promotes tumor angiogenesis through transcriptional regulation of PDGFA in mantle cell lymphoma.
Palomero J; Vegliante MC; Rodríguez ML; Eguileor A; Castellano G; Planas-Rigol E; Jares P; Ribera-Cortada I; Cid MC; Campo E; Amador V
Blood; 2014 Oct; 124(14):2235-47. PubMed ID: 25092176
[TBL] [Abstract][Full Text] [Related]
25. [Expression of SOX11 mRNA in mantle cell lymphoma and its clinical significance].
Wang YY; Yu Z; Yi SH; Li ZJ; Li CH; Xie ZQ; Li F; Zang MR; Hao M; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2012 Jul; 33(7):556-60. PubMed ID: 22967417
[TBL] [Abstract][Full Text] [Related]
26. SOX11 expression in mantle cell lymphoma.
Xu W; Li JY
Leuk Lymphoma; 2010 Nov; 51(11):1962-7. PubMed ID: 20919851
[TBL] [Abstract][Full Text] [Related]
27. Targeting SAMHD1 with hydroxyurea in first-line cytarabine-based therapy of newly diagnosed acute myeloid leukaemia: Results from the HEAT-AML trial.
Jädersten M; Lilienthal I; Tsesmetzis N; Lourda M; Bengtzén S; Bohlin A; Arnroth C; Erkers T; Seashore-Ludlow B; Giraud G; Barkhordar GS; Tao S; Fogelstrand L; Saft L; Östling P; Schinazi RF; Kim B; Schaller T; Juliusson G; Deneberg S; Lehmann S; Rassidakis GZ; Höglund M; Henter JI; Herold N
J Intern Med; 2022 Dec; 292(6):925-940. PubMed ID: 35934913
[TBL] [Abstract][Full Text] [Related]
28. SOX11/PRDX2 axis modulates redox homeostasis and chemoresistance in aggressive mantle cell lymphoma.
De Bolòs A; Sureda-Gómez M; Carreras-Caballé M; Rodríguez ML; Clot G; Beà S; Giné E; Campo E; Balsas P; Amador V
Sci Rep; 2024 Apr; 14(1):7863. PubMed ID: 38570586
[TBL] [Abstract][Full Text] [Related]
29. Cyclin D1-negative blastoid mantle cell lymphoma identified by SOX11 expression.
Zeng W; Fu K; Quintanilla-Fend L; Lim M; Ondrejka S; Hsi ED
Am J Surg Pathol; 2012 Feb; 36(2):214-9. PubMed ID: 22251940
[TBL] [Abstract][Full Text] [Related]
30. Polyclonal antibody targeting SOX11 cannot differentiate mantle cell lymphoma from B-cell non-Hodgkin lymphomas.
Zhang LN; Cao X; Lu TX; Fan L; Wang L; Xu J; Zhang R; Zou ZJ; Wu JZ; Li JY; Xu W
Am J Clin Pathol; 2013 Dec; 140(6):795-800. PubMed ID: 24225745
[TBL] [Abstract][Full Text] [Related]
31. SOX11 regulates the pro-apoptosis signal pathway and predicts a favorable prognosis of mantle cell lymphoma.
Yang W; Wang Y; Yu Z; Li Z; An G; Liu W; Lv R; Ma L; Yi S; Qiu L
Int J Hematol; 2017 Aug; 106(2):212-220. PubMed ID: 28429312
[TBL] [Abstract][Full Text] [Related]
32. SOX11 and HIG-2 are cross-regulated and affect growth in mantle cell lymphoma.
Kuci V; Nordström L; Conrotto P; Ek S
Leuk Lymphoma; 2016 Aug; 57(8):1883-92. PubMed ID: 26757780
[TBL] [Abstract][Full Text] [Related]
33. Low-level expression of SAMHD1 in acute myeloid leukemia (AML) blasts correlates with improved outcome upon consolidation chemotherapy with high-dose cytarabine-based regimens.
Rassidakis GZ; Herold N; Myrberg IH; Tsesmetzis N; Rudd SG; Henter JI; Schaller T; Ng SB; Chng WJ; Yan B; Ng CH; Ravandi F; Andreeff M; Kantarjian HM; Medeiros LJ; Xagoraris I; Khoury JD
Blood Cancer J; 2018 Oct; 8(11):98. PubMed ID: 30341277
[TBL] [Abstract][Full Text] [Related]
34.
Wang T; Yue W; Tang G; Ye M; Yu J; Liu B; Jiao L; Liu X; Yin S; Chen J; Gao L; Yang J; He M
Front Oncol; 2021; 11():763151. PubMed ID: 34976810
[TBL] [Abstract][Full Text] [Related]
35. Highly sensitive and specific
Federmann B; Frauenfeld L; Pertsch H; Borgmann V; Steinhilber J; Bonzheim I; Fend F; Quintanilla-Martinez L
Haematologica; 2020 Mar; 105(3):754-764. PubMed ID: 31296581
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic utility of SOX11 immunohistochemistry in differentiating cutaneous spread of mantle cell lymphoma from primary cutaneous B-cell lymphomas.
Hsi AC; Hurley MY; Lee SJ; Rosman IS; Pang X; Gru A; Schaffer A
J Cutan Pathol; 2016 Apr; 43(4):354-61. PubMed ID: 26762898
[TBL] [Abstract][Full Text] [Related]
37. SOX11 Inhibitors Are Cytotoxic in Mantle Cell Lymphoma.
Jatiani SS; Christie S; Leshchenko VV; Jain R; Kapoor A; Bisignano P; Lee C; Kaniskan HÜ; Edwards D; Meng F; Laganà A; Youssef Y; Wiestner A; Alinari L; Jin J; Filizola M; Aggarwal AK; Parekh S
Clin Cancer Res; 2021 Aug; 27(16):4652-4663. PubMed ID: 34158358
[TBL] [Abstract][Full Text] [Related]
38. The role of SOX11 immunostaining in confirming the diagnosis of mantle cell lymphoma on fine-needle aspiration samples.
Zhang YH; Liu J; Dawlett M; Guo M; Sun X; Gong Y
Cancer Cytopathol; 2014 Dec; 122(12):892-7. PubMed ID: 25056830
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of GLI3 Expression Mediates Chemotherapy Resistance in Acute Myeloid Leukemia.
Freisleben F; Behrmann L; Thaden V; Muschhammer J; Bokemeyer C; Fiedler W; Wellbrock J
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708452
[TBL] [Abstract][Full Text] [Related]
40. Tumorigenic role of Musashi-2 in aggressive mantle cell lymphoma.
Sureda-Gómez M; Balsas P; Rodríguez ML; Nadeu F; De Bolòs A; Eguileor Á; Kulis M; Castellano G; López C; Giné E; Demajo S; Jares P; Martín-Subero JI; Beà S; Campo E; Amador V
Leukemia; 2023 Feb; 37(2):408-421. PubMed ID: 36509891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
